A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
one from each parent, to give someone the full-blown disease. Many people have just one copy, the other being normal. Those who carry the sickle cell trait do not suffer nearly as severely from ...
It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...
(WASHINGTON—Jan. 30, 2025) – A systematic literature review found no evidence to support that physical exertion without rhabdomyolysis (muscle breakdown) or heat injury can cause sudden death for ...
known as having sickle cell trait, increases the risk of blood clots, a risk that is the same among diverse human populations that ... Jan. 30, 2025 — A systematic literature review found no ...
1990; and references therein. Can we predict that natural selection will weed out genetic disease over time? Sickle-cell trait haplotype distribution shows the genetic advantages of this mutation.